Sanjivani Paranteral Share Price | Sanjivani Paranteral Stock Screener
SANJIVIN
Pharmaceuticals
Share Price BSE
₹152.00
▼
-2.95 (-1.90%)
As of July 6, 2026, the Sanjivani Paranteral share price (BSE: SANJIVIN) is ₹152.00, down 1.90% from the previous close, with shares trading between ₹149.00 and ₹155.00, and a 52-week range of ₹129.30–₹254.00.
Analyse SANJIVIN stock price history and track historical price performance.
Use the Sanjivani Paranteral stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sanjivani Paranteral Market Cap
₹185.55 Cr.
SANJIVIN P/E Ratio (TTM)
28.43
Sanjivani Paranteral P/B Ratio
3.95
EPS (TTM)
₹5.49
Dividend Yield
-
Debt to Equity
0.10
SANJIVIN 52 Week High
₹254.00
Sanjivani Paranteral 52 Week Low
₹129.30
Operating Margin
12.00%
Profit Margin
7.14%
SANJIVIN Revenue (TTM)
₹14.00
EBITDA
₹2.00
Net Income
₹1.00
Total Assets
₹88.00
Total Equity
₹48.00
Sanjivani Paranteral Share Price Chart
Screen Sanjivani Paranteral share price with an interactive chart. Analyse SANJIVIN price trends and volatility across different timeframes.
Sanjivani Paranteral Company Profile - Fundamental Screener
Screen Sanjivani Paranteral company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SANJIVIN shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE860D01013
Sanjivani Paranteral Balance Sheet Screener
Screen SANJIVIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 |
|---|---|---|---|
| Assets | |||
| Total Assets | 88 | 78 | 43 |
| Current Assets | 36 | 34 | 29 |
| Fixed Assets | 48 | 21 | 10 |
| Liabilities | |||
| Total Liabilities | 0 | 0 | 0 |
| Current Liabilities | 11 | 7 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 |
| Shareholders' Equity | |||
| Total Equity | 48 | 40 | 28 |
| Share Capital | 12 | 12 | 12 |
| Reserves & Surplus | 36 | 25 | 14 |
Sanjivani Paranteral Income Statement Screener - Profit & Revenue Analysis
Screen Sanjivani Paranteral income statement and profit fundamentals.
Analyze SANJIVIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sanjivani Paranteral share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 | 22 | 16 | 18 | 19 | 18 | 19 | 17 | 13 | 15 |
| Expenses | 12 | 18 | 13 | 15 | 16 | 15 | 15 | 14 | 11 | 13 |
| EBITDA | 2 | 4 | 2 | 3 | 3 | 3 | 3 | 2 | 2 | 2 |
| Operating Profit % | 12.00% | 17.00% | 15.00% | 15.00% | 14.00% | 15.00% | 16.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 4 | 2 | 2 | 3 | 3 | 3 | 2 | 2 | 2 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Net Profit | 1 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| EPS | 0.49 | 2.21 | 1.33 | 1.46 | 1.84 | 1.62 | 1.96 | 1.47 | 1.08 | 1.65 |
Sanjivani Paranteral Cash Flow Screener - Liquidity Fundamentals
Screen SANJIVIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 12 | -11 |
| Investing Activities | -22 | -12 |
| Financing Activities | 11 | 23 |
| Net Cash Flow | 1 | 0 |
Sanjivani Paranteral Shareholding Pattern Screener
See Sanjivani Paranteral shareholding pattern with promoter, FII, and DII holdings.
Check Sanjivani Paranteral promoter holding and ownership changes for SANJIVIN on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Feb | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.26% | 28.87% | 28.87% | 31.20% | 31.20% | 27.67% | 27.67% | 27.67% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 6.04% | 6.15% | 6.15% | 6.03% | 6.04% | 0.00% | 9.70% | 9.36% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 50.05% | 52.43% | 52.60% | 50.99% | 51.06% | 48.46% | 49.98% | 50.67% |
| Other Holding | 12.66% | 12.54% | 12.38% | 11.78% | 11.70% | 23.87% | 12.65% | 12.31% |
| Shareholder Count | 5,933 | 6,447 | 6,429 | 6,307 | 6,017 | 4,800 | 4,911 | 6,166 |
Sanjivani Paranteral Share Dividend Screener - Share Yield Analysis
Check Sanjivani Paranteral dividend history with payout and yield data.
View Sanjivani Paranteral dividend details including ex-dates and amounts for SANJIVIN stock.
Sanjivani Paranteral Stock Index Membership
See which indices include Sanjivani Paranteral stock.
Check SANJIVIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sanjivani Paranteral Market Events Screener - Corporate Actions
Get Sanjivani Paranteral corporate actions including splits, bonuses, and buybacks.
Check Sanjivani Paranteral stock events that may affect SANJIVIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.50 /share | 12.66% | ||
| Annual General Meeting | NA | 23.26% | ||
| Annual General Meeting | NA | 10.60% | ||
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | -5.69% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 24.37% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -3.28% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 1.05% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | -1.67% |
| 2025-02-10 | 2025-02-10 | Quarterly Result Announcement | NA | -4.99% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -5.46% |
| 2024-01-18 | 2024-01-18 | Extraordinary General Meeting | NA | 0.36% |
Sanjivani Paranteral Competitors Screener - Peer Comparison
Screen SANJIVIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 458,945 | 39.71 | 58,220 | 6.38% | 11,565 | 70.99 |
| Divis Laboratories | 182,045 | 69.89 | 10,560 | 8.73% | 2,520 | 60.09 |
| Torrent Pharmaceuticals | 163,222 | 75.43 | 13,886 | 20.34% | 2,138 | 72.77 |
| Cipla | 118,939 | 30.51 | 29,045 | 2.24% | 3,870 | 69.69 |
| Zydus Life Science | 115,506 | 22.41 | 26,720 | 13.65% | 5,242 | 68.21 |
| Dr Reddys Laboratories | 114,174 | 27.60 | 35,059 | 3.90% | 4,158 | 64.81 |
| Lupin | 113,924 | 21.14 | 27,488 | 19.98% | 5,345 | 73.07 |
| Mankind Pharma | 104,963 | 53.93 | 14,278 | 12.03% | 1,750 | 61.95 |
| Aurobindo Pharma | 91,750 | 26.86 | 33,385 | 3.21% | 3,376 | 64.92 |
| Laurus Labs | 82,555 | 93.55 | 6,868 | 22.01% | 890 | 68.43 |
Sanjivani Paranteral Company Announcements - News Screener
Screen SANJIVIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-25 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-11 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-05-29 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-21 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 21St May 2026 | - |
| 2026-05-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-05-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-15 | Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Thursday 21St May 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-05-14 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-05-14 | Audited Standalone And Consolidated Financial Results Along With Audit Report For The Fourth Quarter And Financial Year Ended 31St March 2026 | - |
| 2026-05-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14Th May 2026. | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-05 | Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results Along With Audit Report For The Fourth Quarter And Financial Year Ended 31St March 2026 | - |
| 2026-04-28 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-07 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-02 | Disclosure Under Regulation 31(4) Of The Securities Exchange Board Of India (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 | - |
| 2026-04-01 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-03-30 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |